https://www.elucidacommunications.com/figures/cardiovascular-continuum 2026-03-12 https://www.elucidacommunications.com/figures/omega-6-and-omega-3-fatty-acid-metabolites 2026-03-12 https://www.elucidacommunications.com/figures/epa-vascular-effects 2026-03-12 https://www.elucidacommunications.com/figures/acat1-inhibition 2026-03-12 https://www.elucidacommunications.com/figures/icosapent-ethyl-mechanism 2026-03-12 https://www.elucidacommunications.com/figures/plaque-anatomy 2026-03-12 https://www.elucidacommunications.com/figures/nlrp3-inflammasome 2026-03-12 https://www.elucidacommunications.com/figures/sotagliflozin-and-empagliflozin-membrane-partitioning 2026-03-12 https://www.elucidacommunications.com/figures/epa-and-dha-biosynthetic-pathway-and-effects 2026-03-12 https://www.elucidacommunications.com/figures/pediatric-femur-fracture-types 2026-03-12 https://www.elucidacommunications.com/figures/epa-endothelial-effects 2026-03-12 https://www.elucidacommunications.com/figures/endothelial-dysfunction 2026-03-12 https://www.elucidacommunications.com/figures/srebp-regulation 2026-03-12 https://www.elucidacommunications.com/figures/contrasting-effects-of-epa-and-dha-in-the-membrane 2026-03-12 https://www.elucidacommunications.com/figures/sotagliflozin-and-dual-inhibition 2026-03-12 https://www.elucidacommunications.com/figures/epa-and-ldl 2026-03-12 https://www.elucidacommunications.com/figures/t-cell-activation 2026-03-12 https://www.elucidacommunications.com/figures/epa-and-glp-1 2026-03-12 https://www.elucidacommunications.com/figures/potential-epa-mechanisms 2026-03-12 https://www.elucidacommunications.com/figures/acly-dysregulation 2026-03-12 https://www.elucidacommunications.com/figures/omega-3-fatty-acid-metabolites 2026-03-12 https://www.elucidacommunications.com/figures/lp(a)-and-atorvastatin 2026-03-12